Characterization of Lactobacillus reuteri WQ-Y1 with the ciprofloxacin degradation ability

Chunxiao Qu,Zhen Wu,Daodong Pan,Zhendong Cai,Xiaotao Liu
DOI: https://doi.org/10.1007/s10529-020-03068-9
2021-01-02
Biotechnology Letters
Abstract:As a broad-spectrum fluoroquinolone antibiotic drug, ciprofloxacin (CIP) is frequently used in the treatment of a wide variety of infections. However, the residues of this antibiotic pose a big threat to the aquatic environment and human health. In this research, <i>Lactobacillus reuteri</i> WQ-Y1 with CIP degradation ability was screened and identified.
biotechnology & applied microbiology
What problem does this paper attempt to address?